Unknown

Dataset Information

0

Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.


ABSTRACT: Antibody-antigen conjugates, which promote antigen-presentation by dendritic cells (DC) by means of targeted delivery of antigen to particular DC subsets, represent a powerful vaccination approach. To ensure immunity rather than tolerance induction the co-administration of a suitable adjuvant is paramount. However, co-administration of unlinked adjuvant cannot ensure that all cells targeted by the antibody conjugates are appropriately activated. Furthermore, antigen-presenting cells (APC) that do not present the desired antigen are equally strongly activated and could prime undesired responses against self-antigens. We, therefore, were interested in exploring targeted co-delivery of antigen and adjuvant in cis in form of antibody-antigen-adjuvant conjugates for the induction of anti-tumour immunity. In this study, we report on the assembly and characterization of conjugates consisting of DEC205-specific antibody, the model antigen ovalbumin (OVA) and CpG oligodeoxynucleotides (ODN). We show that such conjugates are more potent at inducing cytotoxic T lymphocyte (CTL) responses than control conjugates mixed with soluble CpG. However, our study also reveals that the nucleic acid moiety of such antibody-antigen-adjuvant conjugates alters their binding and uptake and allows delivery of the antigen and the adjuvant to cells partially independently of DEC205. Nevertheless, antibody-antigen-adjuvant conjugates are superior to antibody-free antigen-adjuvant conjugates in priming CTL responses and efficiently induce anti-tumour immunity in the murine B16 pseudo-metastasis model. A better understanding of the role of the antibody moiety is required to inform future conjugate vaccination strategies for efficient induction of anti-tumour responses.

SUBMITTER: Kreutz M 

PROVIDER: S-EPMC3393736 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.

Kreutz Martin M   Giquel Benoit B   Hu Qin Q   Abuknesha Ram R   Uematsu Satoshi S   Akira Shizuo S   Nestle Frank O FO   Diebold Sandra S SS  

PloS one 20120710 7


Antibody-antigen conjugates, which promote antigen-presentation by dendritic cells (DC) by means of targeted delivery of antigen to particular DC subsets, represent a powerful vaccination approach. To ensure immunity rather than tolerance induction the co-administration of a suitable adjuvant is paramount. However, co-administration of unlinked adjuvant cannot ensure that all cells targeted by the antibody conjugates are appropriately activated. Furthermore, antigen-presenting cells (APC) that d  ...[more]

Similar Datasets

| S-EPMC6660633 | biostudies-literature
2024-08-23 | GSE250159 | GEO
| S-EPMC7309268 | biostudies-literature
| S-EPMC4427876 | biostudies-literature
| S-EPMC3955097 | biostudies-literature
| S-EPMC11185737 | biostudies-literature
| S-EPMC7063246 | biostudies-literature
| S-EPMC9325128 | biostudies-literature
| S-EPMC9499840 | biostudies-literature
| S-EPMC10325888 | biostudies-literature